Please login to the form below

Incyte

J&J’s targeted bladder cancer treatment gets US approval

Despite the first-to-market personalised medicine claim for FGFR in bladder cancer, J&J could soon be joined by Incyte, which has its own oral FGFR inhibitor, Pemigatinib, in phase ... Incyte are also reviewing their candidate in advanced/metastatic or

Combined immunotherapies – potential and pitfalls

The recent failed phase 3 trial of a combination of MSD’s monoclonal antibody Keytruda (pembrolizumab) and InCyte Corporation’s epacadostat in metastatic melanoma is a case in point he says.

CML-Life Patient Support Programme

Incyte listened to what we had to say, and developed something that we’ll actually use. ... CML-Life Patient Support Programme - by Incyte Biosciences with support from The EarthWorks (an Open Health Company).

Think Toddler Sized

CML-Life Patient Support Programme - by Incyte Biosciences with support from The EarthWorks (an Open Health Company).

Small Talk Saves Lives

CML-Life Patient Support Programme - by Incyte Biosciences with support from The EarthWorks (an Open Health Company).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Senior Medical Writer: Salary TBC

Medical Writer/ Senior Medical Writer opportunities – Macclesfie...: competitive salary and benefits package

Good data is nothing without advocacy: ...
My MS journey: one patient's search for innovation: David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.: Can UK-based company be first to develop a universal flu vaccine?...